Cannabis Bioscience International Holdings, Inc.

CIK 1411057 CBIH·Commercial Physical And Biological Research · All EDGAR filings ↗

Refine

Late filing elevated Filing comparison 2026-10-16

Cannabis Bioscience International Holdings, Inc. told the SEC it could not file its quarterly report on time

The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the quarter ended August 31, 2026, cannot be analyzed and completed on a timely basis.

Evidence

Days past due date: 1
Other periodic reports filed: No
Routine: No
Severity: elevated
Source: Form 12b-25 (notification of late filing)
Stated reason: The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the quarter ended August 31, 2026, cannot be analyzed and completed on a timely basis.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing elevated Filing comparison 2026-08-31

Cannabis Bioscience International Holdings, Inc. told the SEC it could not file its annual report on time

The financial information to be contained in the Registrant's Annual Report on Form 10-K for the year ended May 31, 2026, cannot be analyzed and completed on a timely basis.

Evidence

Days past due date: 2
Other periodic reports filed: Yes
Routine: No
Severity: elevated
Source: Form 12b-25 (notification of late filing)
Stated reason: The financial information to be contained in the Registrant's Annual Report on Form 10-K for the year ended May 31, 2026, cannot be analyzed and completed on a timely basis.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing Filing comparison 2026-04-14

Cannabis Bioscience International Holdings, Inc. told the SEC it could not file its quarterly report on time

The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the quarter ended February 28, 2025, cannot be analyzed and completed on a timely basis.

Evidence

Days past due date: 0
Other periodic reports filed: Yes
Routine: Yes
Severity: normal
Source: Form 12b-25 (notification of late filing)
Stated reason: The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the quarter ended February 28, 2025, cannot be analyzed and completed on a timely basis.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing Filing comparison 2026-01-14

Cannabis Bioscience International Holdings, Inc. told the SEC it could not file its quarterly report on time

The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the year ended August 31, 2025, cannot be analyzed and completed on a timely basis.

Evidence

Days past due date: 0
Other periodic reports filed: Yes
Routine: Yes
Severity: normal
Source: Form 12b-25 (notification of late filing)
Stated reason: The financial information to be contained in the Registrant's Quarterly Report on Form 10-Q for the year ended August 31, 2025, cannot be analyzed and completed on a timely basis.
Why: The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗